185 results on '"Kudo, Masatoshi"'
Search Results
2. Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study
3. Reevaluation of Makuuchi’s criteria for resecting hepatocellular carcinoma: A Japanese nationwide survey
4. Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib
5. Progression from early to advanced stage of immune‐related cholangitis
6. Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma
7. Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection
8. Semiquantitative prediction of early response of conventional transcatheter arterial chemoembolization for hepatocellular carcinoma using postprocedural plain cone‐beam computed tomography
9. Reevaluation of Makuuchi's criteria for resecting hepatocellular carcinoma: A Japanese nationwide survey.
10. Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version)
11. Report of the 22nd nationwide follow‐up Survey of Primary Liver Cancer in Japan (2012–2013)
12. Report of the 19th follow-up survey of primary liver cancer in Japan
13. Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)
14. Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents
15. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)
16. Current treatment status of polycystic liver disease in Japan
17. Impact of hepatitis C virus on survival in patients undergoing resection of intrahepatic cholangiocarcinoma: Report of a Japanese nationwide survey
18. Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study
19. Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α ‐fetoprotein: Outcomes by treatment‐emergent ascites
20. Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count
21. Serum amyloid A and C-reactive protein positive nodule in alcoholic liver cirrhosis, hard to make definite diagnosis
22. Report of the 21st Nationwide Follow‐up Survey of Primary Liver Cancer in Japan (2010–2011)
23. Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update
24. Activation of c-Jun N-terminal kinase in non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma
25. Demonstration of quality of care measurement using the Japanese liver cancer registry
26. Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009
27. Treatment of hepatocellular carcinoma during the COVID‐19 outbreak: The Working Group report of JAMTT‐HCC
28. Report of the 20th Nationwide follow‐up survey of primary liver cancer in Japan
29. Report of the 18th follow-up survey of primary liver cancer in Japan
30. Hepatocellular carcinoma in Japan: Epidemiology, diagnosis and radiofrequency ablation: Plenary Session 6: HCC
31. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
32. Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)
33. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
34. Molecular mechanisms of portal vein tolerance
35. Small hepatocellular carcinoma presenting with massive metastasis in the peritoneum, mimicking sarcomatous tumor
36. Review of current staging systems for hepatocellular carcinoma
37. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma
38. Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma
39. International comparison of treatment outcomes based on staging systems
40. Review of 4th Single Topic Conference on HCC: Hepatocellular carcinoma: International consensus and controversies
41. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan
42. Spontaneous regurgitation of portal blood flow normalized by meal intake in a patient with alcoholic liver cirrhosis
43. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
44. Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound–ultrasound overlay fusion for optimal ablation and local controllability
45. Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version)
46. Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
47. Eosionophilic pseudotumor of the liver due to Ascaris suum infection
48. Intrahepatic huge hematoma due to rupture of small hepatocellular adenoma: a case report
49. CEA producing primary hepatic carcinoid
50. Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.